持续血糖监测系统市场按组件、设备类型、使用时长、患者年龄层、应用、分销管道和最终用户划分 - 全球预测 2025-2030

持续血糖监测系统市场预计到 2024 年将达到 44.7 亿美元，2025 年将达到 47.9 亿美元，到 2030 年将达到 68.2 亿美元，复合年增长率为 7.26%。

主要市场统计数据
基准年2024年	44.7亿美元
预计2025年	47.9亿美元
预测年份 2030	68.2亿美元
复合年增长率（%）	7.26%

探索持续血糖监测系统作为塑造全球现代糖尿病管理的关键力量的出现

近年来，持续血糖监测系统透过提供不间断的即时血糖值追踪，重新定义了慢性病管理。这项发展将血糖监测模式从顺序指尖采血转变为持续的数据驱动型方法，使临床医生和患者能够识别趋势、预测波动并主动干预。随着糖尿病盛行率持续上升，医疗保健提供者面临着提供个人化、反应迅速的护理以减少併发症并提高生活品质的挑战。

宣布突破性进展和整合技术，革新即时血糖监测，改善患者预后

感测器微型化、云端连接以及预测演算法的整合正在彻底改变血糖监测格局。现代设备不再孤立运行，而是与智慧型手机、云端资料库和远端监控平台无缝集成，使医疗团队能够近乎即时地做出回应。这种持续向互通性转变正在为数据分析开闢新的途径，提供指导治疗调整和降低急性血糖事件风险的见解。

评估关税对美国持续血糖监测系统成本和供应链动态的影响

2025年修订的关税措施出台，凸显了持续血糖监测系统分销领域供应链的脆弱性。微电子感测器和无线收发器等关键零件的进口关税上调，给製造业带来了成本压力。为此，一些供应商已实施多元化筹资策略，将生产设施迁至更靠近终端市场的地方，或协商替代原材料合同，以缓解运费和关税上涨的影响。

根据组件、设备类型、使用时长、患者人口统计、应用和分销管道进行市场细分

仔细研究连续血糖监测系统的细分市场，可以发现清晰的多维度需求驱动因素和创新路径。从组件分析来看，该行业正在大力投资感测器开发，以提高准确性，同时监测器和接收器也已发展到支援高级警报演算法并与行动应用程式整合。负责无线资料中继的发射器模组继续受益于低能耗通讯协定，从而延长电池寿命并减少维护干预。

了解美洲、中东和非洲以及亚太市场持续血糖监测的区域差异和成长潜力

区域差异在影响连续血糖监测系统的采用率、报销策略和产品供应方面发挥关键作用。在美洲，强大的医疗基础设施和支持性报销政策使主要经济体成为下一代设备的早期采用者。该地区的临床医生越来越多地将远端监测纳入标准治疗通讯协定，报销改革也正在扩大长期穿戴式感测器和整合分析平台的适用范围。

分析推动持续血糖监测系统领先供应商发展的策略性倡议、产品创新和合作

领先的持续血糖监测系统供应商正在利用产品创新、策略联盟和定向收购来保持竞争优势。感测器技术先驱正在改进其演算法以提供预测警报，而其他供应商则专注于无缝平台集成，以提高与电子健康记录和远端医疗服务的互通性。设备製造商和软体开发人员之间的合作正在创建端到端解决方案，将独特的硬体与先进的数据视觉化和远端指导模组相结合。

为产业领导者制定策略，以加速血糖监测的采用，改善患者体验，并优化供应链弹性

寻求利用不断发展的动态的行业领导者应优先将高级分析技术整合到其监测平台中。整合人工智慧和机器学习演算法可以帮助医疗服务提供者提高患者依从性，并提供个人化洞察，从而支援远距临床决策支援。同时，扩大与远端保健平台和电子健康记录供应商的伙伴关係，可以进一步巩固持续血糖监测在综合护理路径中的作用。

为确保持续血糖监测洞察的稳健数据收集、分析和检验采用的严格调查方法框架的详细信息

本分析所采用的调查方法整合了原厂药和二手药研究，以确保定性洞察的深度和准确性。原厂药研究包括与关键意见领袖、内分泌科医生、糖尿病教育工作者和采购经理进行结构化访谈，以检验新兴趋势和营运挑战。这些讨论为临床应用时间表、使用者偏好和区域报销细则提供了背景资讯。

我们摘要了关键的观察结果和未来的考虑，指南相关人员应对持续血糖监测系统不断发展的格局

本执行摘要揭示了影响连续血糖监测系统的多方面因素，从技术突破和关税影响，到细分市场和区域动态。关键观察结果表明，设备创新不仅取决于感测器精度，还取决于连接性、使用者体验和供应链稳健性。同时，不断变化的贸易政策凸显了对敏捷製造和多元化分销网络的需求。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章市场动态

• 人工智慧演算法整合用于CGM系统中的预测血糖控制
• 扩展 CGM 平台，使其能够与胰岛素帮浦和数位健康应用程式互通
• 长期穿戴式连续血糖监测仪微创感测器技术的开发
• 采用非酵素葡萄糖感测方法提高了感测器的稳定性并减少了校准。
• 实施云端基础的数据分析和远端医疗集成，实现即时病患监测
• 双激素输送系统与 CGM 结合，实现自动血糖调节
• 以患者为中心的设计，采用灵活的贴片和长佩戴的感测器，正变得越来越重要
• 监管部门的核准加速了下一代植入式 CGM 设备的普及
• CGM製造商与製药公司建立策略联盟，实现糖尿病个人化治疗
• 感测器小型化和奈米技术的进步提高了准确性并降低了侵入性

第六章 市场洞察

• 波特五力分析
• PESTEL分析

第七章 2025年美国关税的累积影响

8. 持续血糖监测系统市场（按组件）

• 接收器/监视器
• 感应器
• 发送器

9. 持续血糖监测系统市场（依设备类型）

• 整合 CGM 系统
• 独立 CGM 系统

10. 持续血糖监测系统市场（依使用时长）

• 长期植入式连续血糖监测
• 短期可穿戴CGM

11. 持续血糖监测系统市场（依患者年龄层）

• 成人
• 孩子
• 老年人

第 12 章：连续血糖监测系统市场（依应用）

• 妊娠糖尿病
• 1型糖尿病
• 2型糖尿病

13. 持续血糖监测系统市场（依分销管道）

• 离线
• 在线的
  • 电商平台
  • 製造商网站

第 14 章。持续血糖监测系统市场（按最终用户）

• 门诊手术中心
• 居家照护环境
• 医院和诊所
  • 住院药房
  • 门诊药房

15. 美国连续血糖监测系统市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 阿根廷

16. 欧洲、中东和非洲连续血糖监测系统市场

• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 阿拉伯聯合大公国
• 沙乌地阿拉伯
• 南非
• 丹麦
• 荷兰
• 卡达
• 芬兰
• 瑞典
• 奈及利亚
• 埃及
• 土耳其
• 以色列
• 挪威
• 波兰
• 瑞士

17. 亚太地区持续血糖监测系统市场

• 中国
• 印度
• 日本
• 澳洲
• 韩国
• 印尼
• 泰国
• 菲律宾
• 马来西亚
• 新加坡
• 越南
• 台湾

第十八章竞争格局

• 2024年市场占有率分析
• 2024年FPNV定位矩阵
• 竞争分析
  • A. Menarini Diagnostics srl
  • Abbott Laboratories
  • AgaMatrix Inc. by I-Sens Inc.
  • Ascensia Diabetes Care Holdings AG
  • Dexcom, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Insulet Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • Medtrum Technologies Inc.
  • Nemaura Medical Inc.
  • Novo Nordisk A/S
  • NXP Semiconductors NV
  • Senseonics Holdings Inc.
  • Sibionics
  • Signos, Inc.
  • STMicroelectronics NV
  • Tandem Diabetes Care, Inc.
  • Texas Instruments Incorporated
  • Ypsomed Holding AG

第十九章 研究人工智慧

第20章 研究统计

第21章 研究联络人

第22章 研究报导

第23章 附录

The Continuous Glucose Monitoring Systems Market was valued at USD 4.47 billion in 2024 and is projected to grow to USD 4.79 billion in 2025, with a CAGR of 7.26%, reaching USD 6.82 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024]	USD 4.47 billion
Estimated Year [2025]	USD 4.79 billion
Forecast Year [2030]	USD 6.82 billion
CAGR (%)	7.26%

Exploring the Emergence of Continuous Glucose Monitoring Systems as a Pivotal Force Shaping Modern Diabetes Management Practices Globally

In recent years, continuous glucose monitoring systems have redefined chronic disease management by providing uninterrupted, real time tracking of glycemic levels. This evolution has shifted the paradigm from episodic fingerstick testing to a continuous data driven approach, enabling clinicians and patients to identify trends, anticipate fluctuations, and intervene proactively. As diabetes prevalence continues to rise, pressure mounts on healthcare providers to deliver personalized, responsive care that mitigates complications and enhances quality of life.

Amidst this backdrop, technological breakthroughs in sensor accuracy, wireless communication, and user interface design have accelerated adoption among diverse patient populations. Regulatory bodies have responded by refining approval pathways and reimbursement guidelines, fostering an environment where novel devices can transition more swiftly from conception to clinical use. At the same time, integration with digital health platforms and telemedicine services has created new opportunities to collect, analyze, and apply glycemic data within holistic care frameworks.

As we embark on this exploration of system dynamics, it is essential to appreciate how stakeholder collaboration, patient empowerment, and technological innovation converge to shape an ecosystem that supports continuous monitoring. This introduction establishes the context for subsequent analysis, setting the stage for an examination of transformative shifts, tariff influences, segmentation nuances, regional variations, corporate strategies, and actionable recommendations that define today's continuous glucose monitoring landscape.

Unveiling Groundbreaking Advancements and Integrative Technologies Revolutionizing Real Time Glucose Monitoring for Enhanced Patient Outcomes

The landscape of glucose monitoring is undergoing a profound transformation as sensor miniaturization, cloud connectivity, and predictive algorithms converge. Modern devices no longer operate in isolation; they integrate seamlessly with smartphones, cloud databases, and remote monitoring platforms, allowing healthcare teams to respond in near real time. This shift toward continuous interoperability has unlocked new pathways for data analytics, yielding insights that guide therapy adjustments and reduce the risk of acute glycemic events.

Concurrently, breakthroughs in biocompatible materials and energy harvesting techniques have extended sensor lifespans, reducing patient burden and improving long term adherence. Miniature electrodes and advanced polymers now enable implantable systems to function for months without replacement, while wearable patches continue to evolve in shape and form factor to maximize comfort and discretion. Furthermore, artificial intelligence is being harnessed to forecast glycemic excursions, delivering automated alerts that preempt dangerous hypo- or hyperglycemia.

Together, these developments signal a move away from reactive care and toward proactive disease management. Patients are empowered to interpret personalized glucose patterns, clinicians can optimize therapy regimens with unprecedented precision, and payers benefit from reduced hospitalization rates. As we examine how these innovations reshape practice models, the broader implication is clear: glucose monitoring is no longer a diagnostic exercise, but a continuous dialogue between patient, clinician, and technology ecosystem.

Assessing the Impact of Enhanced Tariff Measures on the Cost and Supply Chain Dynamics of Continuous Glucose Monitoring Systems in the United States

The introduction of revised tariff measures in 2025 has brought supply chain fragility to the forefront of continuous glucose monitoring system distribution. Increased import duties on key components, including microelectronic sensors and wireless transceivers, have injected cost pressures into manufacturing pipelines. In response, several suppliers have diversified sourcing strategies, relocating production facilities closer to end markets and negotiating alternative raw material contracts to mitigate freight and duty escalations.

Amidst rising input costs, distributors and healthcare providers have sought to manage affordability concerns by consolidating procurement volumes and revising contract structures. Strategic collaborations between device manufacturers and logistics partners now emphasize inventory optimization and transparent cost pass through, aiming to preserve accessibility for patients who depend on uninterrupted glucose monitoring. At the same time, regulatory authorities are reassessing reimbursement frameworks to accommodate incremental pricing adjustments tied to tariff fluctuations.

Through these adaptations, the industry is demonstrating resilience in the face of policy shifts that could otherwise impede supply continuity. While short term adjustments in pricing tiers and contract terms may be necessary, the long term emphasis remains on fostering stable distribution channels and ensuring that device availability aligns with patient needs. This section highlights the interplay between trade policy and operational strategy, underscoring how tariff landscapes will continue to influence system deployment across the United States.

Delving into Market Segmentation Structured Across Components, Device Types, Usage Durations, Patient Demographics, Applications, and Distribution Channels

A granular examination of continuous glucose monitoring system segmentation reveals distinct demand drivers and innovation pathways across multiple dimensions. When considering component analysis, the industry has witnessed robust investment in sensor development to improve precision, while monitors and receivers have evolved to support advanced alert algorithms and integration with mobile applications. Transmitter modules, responsible for wireless data relay, continue to benefit from low energy consumption protocols that extend battery life and reduce maintenance interventions.

From the perspective of device type, integrated systems that combine sensor and transmitter within a unified wearable platform are gaining traction among patients seeking streamlined form factors. In parallel, standalone systems remain relevant for users who prefer modular configurations or who require rapid sensor replacement without altering monitor infrastructure. Duration of use also differentiates solutions, with long term implantable systems offering discrete, extended wear for patients with demanding adherence requirements, and short term wearable patches providing flexible options for intermittent monitoring or clinical trial settings.

Patient age group segmentation underscores unique user needs. Adult populations drive demand for sophisticated analytics and integration with digital health suites, whereas pediatric and geriatric cohorts prioritize simplicity of use and minimal skin irritation. Application segments further delineate system optimization strategies, as gestational diabetes monitoring calls for compact, easy to manage devices, type 1 diabetes management emphasizes insulin dosing accuracy, and type 2 diabetes patients often require intuitive interfaces that promote lifestyle modifications.

Distribution channel analysis highlights a dual track of offline channels-specialty clinics, pharmacies, and medical device distributors-and online avenues that span both third party eCommerce platforms and manufacturer websites. End user settings range from ambulatory surgical centers deploying perioperative monitoring solutions to home care environments favoring plug-and-play devices, as well as hospitals and clinics that rely on in-house pharmacy networks, including inpatient and outpatient pharmacies, to supply critical components. This segmentation framework illuminates where value creation and competitive differentiation converge across the continuous glucose monitoring ecosystem.

Uncovering Regional Variances and Growth Potential in Continuous Glucose Monitoring Across Americas, Europe Middle East Africa, and Asia Pacific Markets

Regional variation plays a pivotal role in shaping adoption rates, reimbursement strategies, and product offerings for continuous glucose monitoring systems. In the Americas, robust healthcare infrastructure and supportive reimbursement policies have positioned key economies as early adopters of next generation devices. Clinicians in this region increasingly incorporate remote monitoring into standard care protocols, and reimbursement reforms are expanding coverage for extended wear sensors and integrated analytics platforms.

Contrastingly, Europe, the Middle East, and Africa present a mosaic of regulatory frameworks and purchasing power dynamics. Western European countries benefit from centralized health technology assessments that streamline market access, whereas emerging markets in Eastern Europe and the Middle East navigate evolving reimbursement guidelines and logistical constraints. Across Africa, distribution challenges and limited healthcare budgets necessitate cost efficient solutions, sparking interest in partnerships that localize manufacturing and training programs to support clinical adoption.

In the Asia Pacific region, rapid urbanization, escalating diabetes prevalence, and expanding private healthcare expenditures are driving demand for portable, user friendly monitoring solutions. Markets such as Japan and Australia are characterized by early integration of digital health services, while Southeast Asian economies are fostering tiered access models that prioritize affordability and basic functionality. Interregional collaborations and technology transfer initiatives are further accelerating penetration in underserved areas, creating a dynamic environment where regional insights inform global market strategies.

Analyzing the Strategic Movements, Product Innovations, and Collaborations Driving Leading Continuous Glucose Monitoring System Providers Forward

Leading providers of continuous glucose monitoring systems are leveraging product innovation, strategic alliances, and targeted acquisitions to maintain competitive advantage. Pioneers in sensor technology are refining algorithms to deliver predictive alerts, while others focus on seamless platform integration to enhance interoperability with electronic health records and telemedicine services. Joint ventures between device manufacturers and software developers have resulted in end to end solutions that pair proprietary hardware with advanced data visualization and remote coaching modules.

Innovation pipelines are supported by collaborations with academic institutions and healthcare organizations, where real world evidence studies validate device performance across diverse patient cohorts. Intellectual property portfolios are expanded through filings in emerging geographies, ensuring that patented sensor chemistries and wireless protocols are protected globally. Simultaneously, select participants have pursued strategic acquisitions of complementary technology firms to fill product portfolio gaps and accelerate time to market.

In addition to technology partnerships, several providers are optimizing their commercial footprints through enhanced distribution agreements and logistics alliances. These collaborations streamline inventory management, reduce lead times, and support targeted marketing initiatives that educate clinicians and patients on system benefits. The combined effect of these strategic movements is a robust competitive landscape where leadership is defined by both technological differentiation and executional excellence.

Formulating Strategies for Industry Leaders to Accelerate Adoption, Enhance Patient Experience, and Optimize Supply Chain Resilience in Glucose Monitoring

Industry leaders seeking to capitalize on evolving dynamics should prioritize integration of advanced analytics into monitoring platforms. By embedding artificial intelligence and machine learning algorithms, providers can offer personalized insights that improve patient compliance and support remote clinical decision support. Simultaneously, expanding partnerships with telehealth platforms and electronic medical record vendors will cement the role of continuous glucose monitoring in comprehensive care pathways.

To address supply chain vulnerabilities exposed by recent tariff adjustments, organizations should diversify manufacturing locations and develop redundancy protocols for critical components. Engaging with contract development and manufacturing organizations in multiple regions can mitigate disruptions, while negotiating flexible contractual terms with logistics partners will enable rapid response to policy changes. Furthermore, adopting value based pricing models in collaboration with payers can preserve device affordability and secure long term reimbursement commitments.

Patient engagement strategies should be enhanced through user centric design and robust educational programs. Co-creating device features with end users and clinicians will ensure that form factors and interface designs resonate with target demographics. Lastly, ongoing investment in real world evidence generation will strengthen clinical value propositions, support regulatory approvals in new markets, and reinforce stakeholder confidence in system efficacy.

Detailing the Rigorous Methodological Framework Employed to Ensure Robust Data Collection, Analysis, and Validation for Continuous Glucose Monitoring Insights

The research methodology underpinning this analysis combines primary qualitative insights with comprehensive secondary data synthesis to ensure depth and accuracy. Primary research involved structured interviews with key opinion leaders, endocrinologists, diabetes educators, and procurement managers to validate emerging trends and operational challenges. These discussions provided context on clinical adoption timelines, user preferences, and regional reimbursement nuances.

Secondary research encompassed a review of regulatory filings, public company disclosures, industry white papers, and scientific literature to triangulate findings and map technological trajectories. Data extraction focused on device approvals, patent activity, key partnership announcements, and tariff policy documentation. This process was augmented by a meticulous assessment of logistical and distribution frameworks across major healthcare markets.

Throughout the study, a cross functional analytical framework was applied to segment insights by component, device type, usage duration, patient demographics, application, distribution channel, and end user setting. Regional analyses were informed by health technology assessments and national reimbursement guidelines. Finally, all findings underwent multi stage validation with subject matter experts to eliminate bias and confirm relevance for stakeholders across product development, commercialization, and policy domains.

Summarizing Critical Observations and Future Considerations to Guide Stakeholders in Navigating the Evolving Landscape of Continuous Glucose Monitoring Systems

This executive summary has illuminated the multifaceted forces shaping continuous glucose monitoring systems, from technological breakthroughs and tariff influences to granular segmentation and regional dynamics. Critical observations reveal that device innovation is not solely defined by sensor accuracy, but also by connectivity, user experience, and supply chain robustness. At the same time, shifting trade policies underscore the need for agile manufacturing and diversified distribution networks.

Segmentation insights highlight distinct value levers across patient cohorts, application types, and channel preferences, informing how providers can tailor solutions to meet unique clinical and consumer demands. Regional analyses demonstrate that while high income markets prioritize integration and reimbursement alignment, emerging economies are ripe for cost efficient offerings and local manufacturing initiatives. Meanwhile, leading companies continue to differentiate through strategic partnerships, intellectual property expansion, and customer centric commercialization strategies.

Looking ahead, stakeholders must balance innovation with operational resilience, embracing data driven decision making and collaborative frameworks that span technology vendors, healthcare providers, and payers. By synthesizing these strategic imperatives, organizations will be well positioned to navigate an evolving landscape that places continuous monitoring at the heart of diabetes management and preventive care.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Market Sizing & Forecasting

5. Market Dynamics

• 5.1. Integration of artificial intelligence algorithms for predictive glucose management in CGM systems
• 5.2. Expansion of interoperable CGM platforms with insulin pumps and digital health applications
• 5.3. Development of minimally invasive sensor technologies for extended wear continuous glucose monitors
• 5.4. Adoption of non-enzymatic glucose sensing methods to enhance sensor stability and reduce calibration
• 5.5. Implementation of cloud-based data analytics and telehealth integration for real-time patient monitoring
• 5.6. Emergence of dual-hormone delivery systems combined with CGM for automated glucose regulation
• 5.7. Growing emphasis on patient-centric design with flexible patches and extended wear sensors
• 5.8. Regulatory approvals accelerating availability of next-generation implantable CGM devices
• 5.9. Strategic partnerships between CGM manufacturers and pharma companies to personalize diabetes therapies
• 5.10. Advances in sensor miniaturization and nanotechnology to improve accuracy and reduce invasiveness

6. Market Insights

• 6.1. Porter's Five Forces Analysis
• 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Continuous Glucose Monitoring Systems Market, by Component

• 8.1. Introduction
• 8.2. Receivers/Monitors
• 8.3. Sensors
• 8.4. Transmitters

9. Continuous Glucose Monitoring Systems Market, by Type of Device

• 9.1. Introduction
• 9.2. Integrated CGM Systems
• 9.3. Standalone CGM Systems

10. Continuous Glucose Monitoring Systems Market, by Duration of Use

• 10.1. Introduction
• 10.2. Long-Term Implantable CGMs
• 10.3. Short-Term Wearable CGMs

11. Continuous Glucose Monitoring Systems Market, by Patient Age Group

• 11.1. Introduction
• 11.2. Adults
• 11.3. Children
• 11.4. Geriatric

12. Continuous Glucose Monitoring Systems Market, by Application

• 12.1. Introduction
• 12.2. Gestational Diabetes
• 12.3. Type 1 Diabetes
• 12.4. Type 2 Diabetes

13. Continuous Glucose Monitoring Systems Market, by Distribution Channel

• 13.1. Introduction
• 13.2. Offline
• 13.3. Online
  • 13.3.1. eCommerce Platforms
  • 13.3.2. Manufacturer Websites

14. Continuous Glucose Monitoring Systems Market, by End User

• 14.1. Introduction
• 14.2. Ambulatory Surgical Centers
• 14.3. Home Care Settings
• 14.4. Hospitals & Clinics
  • 14.4.1. Inpatient Pharmacies
  • 14.4.2. Outpatient Pharmacies

15. Americas Continuous Glucose Monitoring Systems Market

• 15.1. Introduction
• 15.2. United States
• 15.3. Canada
• 15.4. Mexico
• 15.5. Brazil
• 15.6. Argentina

16. Europe, Middle East & Africa Continuous Glucose Monitoring Systems Market

• 16.1. Introduction
• 16.2. United Kingdom
• 16.3. Germany
• 16.4. France
• 16.5. Russia
• 16.6. Italy
• 16.7. Spain
• 16.8. United Arab Emirates
• 16.9. Saudi Arabia
• 16.10. South Africa
• 16.11. Denmark
• 16.12. Netherlands
• 16.13. Qatar
• 16.14. Finland
• 16.15. Sweden
• 16.16. Nigeria
• 16.17. Egypt
• 16.18. Turkey
• 16.19. Israel
• 16.20. Norway
• 16.21. Poland
• 16.22. Switzerland

17. Asia-Pacific Continuous Glucose Monitoring Systems Market

• 17.1. Introduction
• 17.2. China
• 17.3. India
• 17.4. Japan
• 17.5. Australia
• 17.6. South Korea
• 17.7. Indonesia
• 17.8. Thailand
• 17.9. Philippines
• 17.10. Malaysia
• 17.11. Singapore
• 17.12. Vietnam
• 17.13. Taiwan

18. Competitive Landscape

• 18.1. Market Share Analysis, 2024
• 18.2. FPNV Positioning Matrix, 2024
• 18.3. Competitive Analysis
  • 18.3.1. A. Menarini Diagnostics s.r.l
  • 18.3.2. Abbott Laboratories
  • 18.3.3. AgaMatrix Inc. by I-Sens Inc.
  • 18.3.4. Ascensia Diabetes Care Holdings AG
  • 18.3.5. Dexcom, Inc.
  • 18.3.6. F. Hoffmann-La Roche Ltd.
  • 18.3.7. Insulet Corporation
  • 18.3.8. Johnson & Johnson Services, Inc.
  • 18.3.9. Medtronic PLC
  • 18.3.10. Medtrum Technologies Inc.
  • 18.3.11. Nemaura Medical Inc.
  • 18.3.12. Novo Nordisk A/S
  • 18.3.13. NXP Semiconductors N.V.
  • 18.3.14. Senseonics Holdings Inc.
  • 18.3.15. Sibionics
  • 18.3.16. Signos, Inc.
  • 18.3.17. STMicroelectronics N.V.
  • 18.3.18. Tandem Diabetes Care, Inc.
  • 18.3.19. Texas Instruments Incorporated
  • 18.3.20. Ypsomed Holding AG

19. ResearchAI

20. ResearchStatistics

21. ResearchContacts

22. ResearchArticles

23. Appendix

LIST OF FIGURES

• FIGURE 1. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET RESEARCH PROCESS
• FIGURE 2. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 3. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 4. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
• FIGURE 6. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2024 VS 2030 (%)
• FIGURE 8. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2024 VS 2030 (%)
• FIGURE 10. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
• FIGURE 12. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 13. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 14. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 15. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
• FIGURE 16. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 17. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
• FIGURE 18. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 19. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 20. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 21. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 22. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 25. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 26. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 27. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 28. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2024
• FIGURE 29. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: RESEARCHAI
• FIGURE 30. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: RESEARCHSTATISTICS
• FIGURE 31. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: RESEARCHCONTACTS
• FIGURE 32. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET: RESEARCHARTICLES

LIST OF TABLES

• TABLE 1. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2025-2030 (USD MILLION)
• TABLE 5. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 7. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 9. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
• TABLE 11. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY RECEIVERS/MONITORS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY RECEIVERS/MONITORS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 13. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SENSORS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SENSORS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 15. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TRANSMITTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TRANSMITTERS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 17. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025-2030 (USD MILLION)
• TABLE 19. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INTEGRATED CGM SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INTEGRATED CGM SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 21. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STANDALONE CGM SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STANDALONE CGM SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 23. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025-2030 (USD MILLION)
• TABLE 25. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY LONG-TERM IMPLANTABLE CGMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY LONG-TERM IMPLANTABLE CGMS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 27. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SHORT-TERM WEARABLE CGMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SHORT-TERM WEARABLE CGMS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 29. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
• TABLE 31. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 33. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CHILDREN, BY REGION, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CHILDREN, BY REGION, 2025-2030 (USD MILLION)
• TABLE 35. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
• TABLE 37. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 39. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 41. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 43. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 45. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
• TABLE 47. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 49. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
• TABLE 51. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ECOMMERCE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 53. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY MANUFACTURER WEBSITES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 55. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
• TABLE 57. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 59. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 61. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 63. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2030 (USD MILLION)
• TABLE 65. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INPATIENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INPATIENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 67. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY OUTPATIENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY OUTPATIENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
• TABLE 69. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
• TABLE 71. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
• TABLE 72. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
• TABLE 73. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2024 (USD MILLION)
• TABLE 74. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025-2030 (USD MILLION)
• TABLE 75. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2024 (USD MILLION)
• TABLE 76. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025-2030 (USD MILLION)
• TABLE 77. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 78. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
• TABLE 79. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 80. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 81. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 82. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
• TABLE 83. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
• TABLE 84. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
• TABLE 85. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 86. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 87. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
• TABLE 88. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
• TABLE 89. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 90. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 91. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
• TABLE 92. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
• TABLE 93. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2024 (USD MILLION)
• TABLE 94. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025-2030 (USD MILLION)
• TABLE 95. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2024 (USD MILLION)
• TABLE 96. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025-2030 (USD MILLION)
• TABLE 97. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 98. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
• TABLE 99. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 100. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 101. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 102. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
• TABLE 103. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
• TABLE 104. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
• TABLE 105. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 106. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 107. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
• TABLE 108. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
• TABLE 109. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
• TABLE 110. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
• TABLE 111. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
• TABLE 112. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
• TABLE 113. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2024 (USD MILLION)
• TABLE 114. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025-2030 (USD MILLION)
• TABLE 115. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2024 (USD MILLION)
• TABLE 116. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025-2030 (USD MILLION)
• TABLE 117. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 118. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
• TABLE 119. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 120. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 121. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 122. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
• TABLE 123. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
• TABLE 124. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
• TABLE 125. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 126. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 127. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
• TABLE 128. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
• TABLE 129. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
• TABLE 130. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
• TABLE 131. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2024 (USD MILLION)
• TABLE 132. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025-2030 (USD MILLION)
• TABLE 133. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2024 (USD MILLION)
• TABLE 134. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025-2030 (USD MILLION)
• TABLE 135. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 136. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
• TABLE 137. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 138. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 139. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 140. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
• TABLE 141. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
• TABLE 142. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
• TABLE 143. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 144. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 145. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
• TABLE 146. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
• TABLE 147. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
• TABLE 148. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
• TABLE 149. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2024 (USD MILLION)
• TABLE 150. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025-2030 (USD MILLION)
• TABLE 151. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2024 (USD MILLION)
• TABLE 152. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025-2030 (USD MILLION)
• TABLE 153. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 154. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
• TABLE 155. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 156. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 157. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 158. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
• TABLE 159. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
• TABLE 160. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
• TABLE 161. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 162. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 163. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
• TABLE 164. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
• TABLE 165. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
• TABLE 166. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
• TABLE 167. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2024 (USD MILLION)
• TABLE 168. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025-2030 (USD MILLION)
• TABLE 169. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2024 (USD MILLION)
• TABLE 170. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025-2030 (USD MILLION)
• TABLE 171. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 172. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
• TABLE 173. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 174. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 175. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 176. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
• TABLE 177. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
• TABLE 178. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
• TABLE 179. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 180. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 181. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
• TABLE 182. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
• TABLE 183. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
• TABLE 184. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
• TABLE 185. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2024 (USD MILLION)
• TABLE 186. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025-2030 (USD MILLION)
• TABLE 187. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2024 (USD MILLION)
• TABLE 188. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025-2030 (USD MILLION)
• TABLE 189. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 190. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
• TABLE 191. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 192. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 193. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 194. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
• TABLE 195. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
• TABLE 196. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
• TABLE 197. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 198. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 199. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
• TABLE 200. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
• TABLE 201. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 202. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
• TABLE 203. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
• TABLE 204. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
• TABLE 205. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2024 (USD MILLION)
• TABLE 206. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025-2030 (USD MILLION)
• TABLE 207. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2024 (USD MILLION)
• TABLE 208. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025-2030 (USD MILLION)
• TABLE 209. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 210. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
• TABLE 211. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 212. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 213. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 214. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
• TABLE 215. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
• TABLE 216. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
• TABLE 217. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 218. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 219. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
• TABLE 220. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
• TABLE 221. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
• TABLE 222. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
• TABLE 223. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2024 (USD MILLION)
• TABLE 224. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025-2030 (USD MILLION)
• TABLE 225. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2024 (USD MILLION)
• TABLE 226. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025-2030 (USD MILLION)
• TABLE 227. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 228. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
• TABLE 229. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 230. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 231. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 232. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
• TABLE 233. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
• TABLE 234. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
• TABLE 235. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 236. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 237. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
• TABLE 238. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
• TABLE 239. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
• TABLE 240. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
• TABLE 241. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2024 (USD MILLION)
• TABLE 242. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025-2030 (USD MILLION)
• TABLE 243. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2024 (USD MILLION)
• TABLE 244. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025-2030 (USD MILLION)
• TABLE 245. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 246. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
• TABLE 247. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 248. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 249. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 250. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
• TABLE 251. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
• TABLE 252. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
• TABLE 253. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 254. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 255. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
• TABLE 256. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
• TABLE 257. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
• TABLE 258. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
• TABLE 259. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2024 (USD MILLION)
• TABLE 260. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025-2030 (USD MILLION)
• TABLE 261. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2024 (USD MILLION)
• TABLE 262. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025-2030 (USD MILLION)
• TABLE 263. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 264. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
• TABLE 265. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 266. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 267. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
• TABLE 268. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
• TABLE 269. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2018-2024 (USD MILLION)
• TABLE 270. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ONLINE, 2025-2030 (USD MILLION)
• TABLE 271. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 272. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
• TABLE 273. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2024 (USD MILLION)
• TABLE 274. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOSPITALS & CLINICS, 2025-2030 (USD MILLION)
• TABLE 275. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
• TABLE 276. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2025-2030 (USD MILLION)
• TABLE 277. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2018-2024 (USD MILLION)
• TABLE 278. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE OF DEVICE, 2025-2030 (USD MILLION)
• TABLE 279. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2018-2024 (USD MILLION)
• TABLE 280. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DURATION OF USE, 2025-2030 (USD MILLION)
• TABLE 281. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 282. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
• TABLE 283. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 284. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
• TABLE 285. ITALY CONTINU